Stockscreener 앱 받기
2.21
2.64%
-0.06
시간 외 거래:
2.21
Nuvation Bio Inc 주식(NUVB)의 최신 뉴스
Nuvation Bio Inc. (NYSE:NUVB) Short Interest Up 14.3% in January - MarketBeat
Kuehn Law Encourages Investors of Nuvation Bio Inc. to Contact Law Firm - The Eastern Progress Online
What Do Wall Street Analysts Think About Nuvation Bio Inc (NYSE: NUVB) Stock? - Stocks Register
Peapod Lane Capital LLC Makes New $1.04 Million Investment in Nuvation Bio Inc. (NYSE:NUVB) - MarketBeat
Nuvation Bio executive departs after key milestones By Investing.com - Investing.com Nigeria
Nuvation Bio executive departs after key milestones - MSN
Nuvation BioPending Approval Shot In ROSL+ NSCLS Looks A Major Upside Catalyst (NUVB) - Seeking Alpha
Nuvation Bio CEO Departs After Achieving Key Goals - TipRanks
Bullish Nuvation Bio Insiders Loaded Up On US$720.1k Of Stock - Simply Wall St
Nuvation Bio Inc (NUVB)’s results reveal risk - US Post News
Nuvation Bio : Corporate Presentation (February 2025) - Marketscreener.com
The Significance of Moving Averages in Nuvation Bio Inc Inc. (NUVB) Price Performance - The InvestChronicle
Nuvation Bio Inc [NUVB] stock for 162,883 USD was sold by Wang Junyuan Jerry - Knox Daily
Understanding the Risks of Investing in Nuvation Bio Inc (NUVB) - Knox Daily
Nuvation Bio Inc (NUVB) requires closer examination - US Post News
Nuvation Bio Inc (NYSE: NUVB) Could Pass $7 In One Year Stock Forecast - Stocks Register
Nuvation Bio launches EAP for lung cancer drug taletrectinib - MSN
Nuvation Bio Starts Expanded Access Program for Lung Cancer Drug -February 03, 2025 at 10:41 am EST - Marketscreener.com
Nuvation Bio Announces Expanded Access Program in the U.S. for Taletrectinib in Advanced ROS1-positive Non-Small Cell Lung Cancer - Marketscreener.com
With 46% stake, Nuvation Bio Inc. (NYSE:NUVB) seems to have captured institutional investors' interest - Yahoo Finance
HC Wainwright Cuts Earnings Estimates for Nuvation Bio - Defense World
HC Wainwright Decreases Earnings Estimates for Nuvation Bio - MarketBeat
Assenagon Asset Management S.A. Sells 309,176 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
JPMorgan Chase & Co. Increases Position in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
JPMorgan Chase & Co. Grows Stock Holdings in Nuvation Bio Inc. (NYSE:NUVB) - MarketBeat
Assenagon Asset Management S.A. Reduces Stock Holdings in Nuvation Bio Inc. (NYSE:NUVB) - MarketBeat
Nuvation Bio (NYSE:NUVB) Price Target Raised to $11.00 - Defense World
Nuvation Bio (NYSE:NUVB) Shares Down 3.8%Here's What Happened - MarketBeat
HC Wainwright Forecasts Strong Price Appreciation for Nuvation Bio (NYSE:NUVB) Stock - MarketBeat
Apple To $280? Here Are 10 Top Analyst Forecasts For Thursday - Benzinga
Nuvation Bio Inc. (NYSE:NUVB) Short Interest Update - MarketBeat
Nuvation Bio (NYSE:NUVB) Trading Down 5.6%Should You Sell? - MarketBeat
Jane Street Group LLC Decreases Stake in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio Inc. (NYSE:NUVB) Holdings Decreased by Jane Street Group LLC - MarketBeat
HC Wainwright Predicts Stronger Earnings for Nuvation Bio - Defense World
FY2024 EPS Estimate for Nuvation Bio Increased by Analyst - MarketBeat
Nuvation Bio (NYSE:NUVB) Stock Price Down 8.3%Here's Why - MarketBeat
Nuvation Bio's SWOT analysis: oncology firm's stock faces pivotal year By Investing.com - Investing.com Canada
Principal Financial Group Inc. Reduces Stock Position in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio's SWOT analysis: oncology firm's stock faces pivotal year - Investing.com
Nuvation Bio's (NUVB) Outperform Rating Reiterated at Royal Bank of Canada - MarketBeat
Nuvation Bio (NYSE:NUVB) Shares Gap UpHere's What Happened - MarketBeat
FDA progress and strong trial data drive positive outlook for Nuvation Bio stock - Investing.com Australia
Nuvation Bio (NYSE:NUVB) Given Buy Rating at HC Wainwright - Defense World
Nuvation Bio price target raised to $10 from $6 at RBC Capital - Nasdaq
Nuvation Bio’s (NUVB) “Outperform” Rating Reaffirmed at Wedbush - Defense World
Wedbush Reiterates Outperform Rating for Nuvation Bio (NYSE:NUVB) - MarketBeat
Nuvation Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Lelezard
0.27%
3.05%
자본화:
|
볼륨(24시간):